KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cvs Health (CVS) Income from Non-Controlling Interests (2016 - 2025)

Cvs Health's Income from Non-Controlling Interests history spans 14 years, with the latest figure at -$20.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Income from Non-Controlling Interests rose 4.76% year-over-year to -$20.0 million, compared with a TTM value of -$40.0 million through Dec 2025, down 42.86%, and an annual FY2025 reading of -$40.0 million, down 42.86% over the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was -$20.0 million at Cvs Health, down from -$15.0 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $13.0 million in Q2 2023, with the low at -$21.0 million in Q4 2024.
  • Average Income from Non-Controlling Interests over 5 years is -$2.0 million, with a median of $1.0 million recorded in 2021.
  • Year-over-year, Income from Non-Controlling Interests surged 500.0% in 2023 and then crashed 2200.0% in 2024.
  • Tracing CVS's Income from Non-Controlling Interests over 5 years: stood at -$10.0 million in 2021, then surged by 80.0% to -$2.0 million in 2022, then surged by 150.0% to $1.0 million in 2023, then crashed by 2200.0% to -$21.0 million in 2024, then increased by 4.76% to -$20.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Income from Non-Controlling Interests are -$20.0 million (Q4 2025), -$15.0 million (Q3 2025), and -$8.0 million (Q2 2025).